Gotham City Research Report | At what point are Grifols’ communication and governance problems?
The end of Grifols’ conference call with its investors to dispel any doubts about the contents expressed by the bearish fund Gotham City Research was approaching when one of the participants brought up the elephant in the room: When will pharmaceutical governance improve? To which the company’s executive chairman and CEO, Thomas Glanzmann, quickly acknowledged … Read more